Watch my weekly webcast on COVID-19 with my colleague Daryl Jones, Director of Research at Hedgeye.
On this week's webcast, I cover as usual a host of emerging topics on the C19 front, from overall case and death numbers to the emerging economic impact.
In particular, I talk about "smart suppression" alternatives to the all-or-nothing dilemma (stop the virus or stop the economy) currently facing policy makers. Where are such approaches now being carried out successfully? What does the United States need to do to adopt such an approach?
Obviously, the fast-tracking of promising anti-virals would improve the public-health outcome no matter what approach we adopt. I walk viewers through the basic biology of SARS-Cov-2 and explain how the most promising off-label anti-virals can be categorized by their impact on how the virion enters the cell and wreaks its havoc.
We also take questions from viewers and listeners.
|
Subscribers: CLICK HERE |
